|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 112.91 USD | -1.16% |
|
+2.81% | +224.38% |
| 07-29 | Corcept Therapeutics Incorporated, Q2 2026 Earnings Call, Jul 29, 2026 | |
| 07-29 | (CORT) Corcept Therapeutics Expects Full Year 2026 Revenue Range $1.1B - $1.2B, vs. FactSet Est of $999.5M | MT |
| Market Cap | 12.35B 10.69B 9.99B 9.13B 17.21B 1,178B 17.48B 117B 45.98B 589B 46.37B 45.35B 1,962B | P/E 2026 * |
56.4x | P/E 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 12.13B 10.51B 9.82B 8.97B 16.91B 1,157B 17.18B 115B 45.18B 579B 45.56B 44.57B 1,928B | EV / Sales 2026 * |
10.6x | EV / Sales 2027 * | 6.74x |
| Free-Float |
66.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Corcept Therapeutics Incorporated
| 1 day | -1.16% | ||
| 1 week | +2.81% | ||
| Current month | -1.40% | ||
| 1 month | +31.41% | ||
| 3 months | +120.48% | ||
| 6 months | +176.48% | ||
| Current year | +224.38% |
| 1 week | 107.32 |  | 114.71 |
| 1 month | 84.88 | | 122.21 |
| Current year | 28.66 | | 122.21 |
| 1 year | 28.66 | | 122.21 |
| 3 years | 20.84 | | 122.21 |
| 5 years | 15.82 | | 122.21 |
| 10 years | 5.24 | | 122.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
CEO | Chief Executive Officer | 68 | 1998-12-31 |
Atabak Mokari
DFI | Director of Finance/CFO | 49 | 2021-02-28 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 48 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
BRD | Director/Board Member | 68 | 1998-12-31 |
James Wilson
CHM | Chairman | 82 | 1998-12-31 |
David Mahoney
BRD | Director/Board Member | 71 | 2004-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/4/26 | Fiscal year | Executive/Senior Manager | 11,100 | 0.0103% | ||
| 8/3/26 | Sell | Chief Technology Officer | -1,540 | 0.0014% | ||
| 8/3/26 | Fiscal year | Executive/Senior Manager | 60,915 | 0.0564% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.16% | +2.81% | +56.85% | +265.68% | 12.35B | |
| -0.84% | +9.58% | +92.47% | +131.43% | 1,098B | |
| -1.10% | +1.70% | +49.16% | +49.14% | 631B | |
| -0.06% | +1.77% | +24.91% | +63.04% | 438B | |
| -0.99% | +3.08% | +49.70% | +39.05% | 368B | |
| -0.69% | +0.93% | +30.97% | +38.53% | 298B | |
| -0.94% | +1.11% | +7.56% | +7.62% | 251B | |
| -0.67% | +6.20% | +45.29% | +57.79% | 226B | |
| +0.34% | -0.13% | -4.77% | -50.50% | 209B | |
| +1.38% | -0.01% | +12.26% | +69.04% | 165B | |
| Average | -0.50% | +1,502.56% | +36.44% | +67.08% | 369.67B | |
| Weighted average by Cap. | -0.65% | +1,327.42% | +50.00% | +67.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.15B 993M 928M 848M 1.6B 109B 1.62B 10.88B 4.27B 54.72B 4.31B 4.21B 182B | 1.76B 1.53B 1.43B 1.3B 2.46B 168B 2.49B 16.72B 6.56B 84.06B 6.62B 6.47B 280B |
| Net income | 242M 210M 196M 179M 337M 23.09B 343M 2.3B 901M 11.55B 909M 889M 38.47B | 645M 559M 522M 477M 899M 61.53B 913M 6.12B 2.4B 30.78B 2.42B 2.37B 103B |
| Net Debt | -213M -185M -173M -158M -297M -20.35B -302M -2.02B -794M -10.18B -801M -784M -33.91B | -474M -411M -384M -351M -661M -45.23B -671M -4.5B -1.77B -22.63B -1.78B -1.74B -75.35B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-11 | US$112.89 | -1.18% | 66,606 |
| 26-08-10 | US$114.23 | +3.12% | 1,256,088 |
| 26-08-07 | US$110.77 | +2.61% | 769,042 |
| 26-08-06 | US$107.95 | -2.48% | 761,834 |
| 26-08-05 | US$110.69 | +0.81% | 846,859 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CORT Stock
Select your edition
All financial news and data tailored to specific country editions
